Premium
COVID‐19 complicating perioperative management of LVAD implantation: A case report and systematic review
Author(s) -
Belfort Deborah de Sá Pereira,
Biselli Bruno,
Ávila Mônica Samuel,
Lira Maria Tereza Sampaio de Sousa,
Galas Filomena Regina Barbosa Gomes,
Steffen Samuel Padovani,
Gaiotto Fabio Antonio,
Jatene Fabio Biscegli,
Bocchi Edimar Alcides,
Ferreira Silvia Moreira Ayub
Publication year - 2021
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.15690
Subject(s) - medicine , perioperative , covid-19 , pneumonia , population , mechanical ventilation , ventricular assist device , inotrope , heart failure , intensive care medicine , disease , surgery , cardiology , infectious disease (medical specialty) , environmental health
The coronavirus 2019 disease (COVID‐19) affected 125 million people worldwide and caused 2.7 million deaths. Some comorbidities are associated with worse prognosis and left ventricular assist device (LVAD) recipients are probably part of this high‐risk population. We report a 31‐year‐old male patient who developed COVID‐19 during LVAD implantation. His postoperative period was complicated by severe pneumonia and mechanical ventilation (MV) leading to right ventricular failure (RVF) and inotrope necessity. He experienced multiple complications, but eventually recovered. We present a systematic review of LVAD recipients and COVID‐19. Among 14 patients, the mean age was 62.7 years, 78.5% were male. A total of 5 patients (35.7%) required MV and 3 patients (21.4%) died. A total of 2 patients (14.2%) had thromboembolic events. This case and systematic review suggest LVAD recipients are at particular risk of unfavorable outcomes and they may be more susceptible to RVF in the setting of COVID‐19, particularly during perioperative period.